Human FOXP3+ regulatory T cells in transplantation
- PMID: 19538489
- PMCID: PMC2724649
- DOI: 10.1111/j.1600-6143.2009.02704.x
Human FOXP3+ regulatory T cells in transplantation
Abstract
CD4+CD25+FOXP3+ suppressive regulatory T cells (Treg) represent a subset of immune regulatory cells. Based on experimental results, Treg have recently been considered as a potential treatment option in several diseases. Compared with murine Treg, human CD4+CD25+FOXP3+ cells are less well characterized and understood, so a thorough understanding of their biology is vital before clinical applications can be initiated. This review summarizes knowledge on generation, phenotypic characteristics and function of human Treg. The possible role of these cells in organ transplantation, as well as interactions between immunosuppression and Treg are also discussed.
References
-
- Scheffold A, Murphy KM, Höfer T. Competition for cytokines: Treg cells take all. Nat Immunol. 2007;8(12):1285–1287. - PubMed
-
- Wood KJ, Sakaguchi S, Regulatory T. cells in transplantation tolerance. Nat Rev Immunol. 2003;3(3):199–210. - PubMed
-
- Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol. 2007;8(12):1353–1362. - PubMed
-
- Ludwig-Portugall I, Hamilton-Williams EE, Gottschalk C, Kurts C. Cutting Edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J Immunol. 2008;181(7):4447–4451. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials